Cargando…

Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer

Prostate cancer is a disease with heterogeneity of multiple gene transcriptomes and biological signaling pathways involved in tumor development. The prostate transmembrane protein, androgen induced 1 (PMEPA1), a multifunctional protein played critical roles in prostate tumorigenesis. The pleiotropic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharad, Shashwat, Dillman, Allissa Amanda, Sztupinszki, Zsófia M., Szallasi, Zoltan, Rosner, Inger, Cullen, Jennifer, Srivastava, Shiv, Srinivasan, Alagarsamy, Li, Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996919/ https://www.ncbi.nlm.nih.gov/pubmed/32064040 http://dx.doi.org/10.18632/oncotarget.27406

Ejemplares similares

Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer
por: Sharad, Shashwat, et al.
Publicado: (2019)

PMEPA1 Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer
por: Sharad, Shashwat, et al.
Publicado: (2020)

Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer
por: Sharad, Shashwat, et al.
Publicado: (2014)

Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR, NEDD4 and PTEN
por: Li, Hua, et al.
Publicado: (2015)

Editorial: Identification of therapeutic targets and novel biomarkers in prostate cancer volume II
por: Sharad, Shashwat, et al.
Publicado: (2023)

Curcumin-Gene Expression Response in Hormone Dependent and Independent Metastatic Prostate Cancer Cells
por: Katta, Shilpa, et al.
Publicado: (2019)

PMEPA1 isoform a drives progression of glioblastoma by promoting protein degradation of the Hippo pathway kinase LATS1
por: Ji, Jianxiong, et al.
Publicado: (2019)

Intratumoral T-cell and B-cell receptor architecture associates with distinct immune tumor microenvironment features and clinical outcomes of anti-PD-1/L1 immunotherapy
por: Schina, Aimilia, et al.
Publicado: (2023)

TMEPAI/PMEPA1 enhances tumorigenic activities in lung cancer cells
por: Vo Nguyen, Thanh Thao, et al.
Publicado: (2014)

TMEPAI/PMEPA1 Is a Positive Regulator of Skeletal Muscle Mass
por: Hagg, Adam, et al.
Publicado: (2020)

A major genetic accelerator of cancer diagnosis: rs867228 in FPR1
por: Sztupinszki, Zsofia, et al.
Publicado: (2021)

Estimation of alternative splicing isoform frequencies from RNA-Seq data
por: Nicolae, Marius, et al.
Publicado: (2011)

PMEPA1/TMEPAI Is a Unique Tumorigenic Activator of AKT Promoting Proteasomal Degradation of PHLPP1 in Triple-Negative Breast Cancer Cells
por: Haque, Md. Anwarul, et al.
Publicado: (2021)

NSMAP: A method for spliced isoforms identification and quantification from RNA-Seq
por: Xia, Zheng, et al.
Publicado: (2011)

PMEPA1 guards against TGF-β-mediated prostate cancer bone metastasis
por: Blee, Alexandra M., et al.
Publicado: (2016)

PMEPA1 Serves as a Prognostic Biomarker and Correlates with Immune Infiltrates in Cervical Cancer
por: Li, Jing, et al.
Publicado: (2022)

A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients
por: Le Naour, Julie, et al.
Publicado: (2022)

PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer
por: Dillon, Kasia M., et al.
Publicado: (2022)

Increased Smad3 and reduced Smad2 levels mediate the functional switch of TGF-β from growth suppressor to growth and metastasis promoter through TMEPAI/PMEPA1 in triple negative breast cancer
por: Singha, Prajjal K., et al.
Publicado: (2019)

Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer
por: Rastogi, Anshu, et al.
Publicado: (2014)

Systematically Differentiating Functions for Alternatively Spliced Isoforms through Integrating RNA-seq Data
por: Eksi, Ridvan, et al.
Publicado: (2013)

PMEPA1 Is a Prognostic Biomarker That Correlates With Cell Malignancy and the Tumor Microenvironment in Bladder Cancer
por: Qiu, Dongxu, et al.
Publicado: (2021)

PMEPA1 induces EMT via a non‐canonical TGF‐β signalling in colorectal cancer
por: Zhang, Lei, et al.
Publicado: (2019)

Migrating the SNP array-based homologous recombination deficiency measures to next generation sequencing data of breast cancer
por: Sztupinszki, Zsofia, et al.
Publicado: (2018)

SpliceNet: recovering splicing isoform-specific differential gene networks from RNA-Seq data of normal and diseased samples
por: Yalamanchili, Hari Krishna, et al.
Publicado: (2014)

High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone
por: Hirokawa, Yoshifumi S., et al.
Publicado: (2007)

Messenger RNA expression, splicing and editing in the embryonic and adult mouse cerebral cortex
por: Dillman, Allissa A., et al.
Publicado: (2013)

Detecting differential alternative splicing events in scRNA-seq with or without Unique Molecular Identifiers
por: Hu, Yu, et al.
Publicado: (2020)

The “ NF-ĸ B interacting long noncoding RNA” ( NKILA) transcript is antisense to cancer-associated gene PMEPA1
por: Dijkstra, Johannes M., et al.
Publicado: (2015)

Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag
por: Rastogi, Anshu, et al.
Publicado: (2016)

Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence
por: Yan, Wusheng, et al.
Publicado: (2019)

Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy
por: Lindgaard, Sidsel C., et al.
Publicado: (2022)

Colon cancer subtypes: concordance, effect on survival and selection of the most representative preclinical models
por: Sztupinszki, Zsófia, et al.
Publicado: (2016)

Loss of miR-449a in ERG-associated prostate cancer promotes the invasive phenotype by inducing SIRT1
por: Kumar, Parameet, et al.
Publicado: (2016)

Hdac3 deletion in myeloid progenitor cells enhances bone healing in females and limits osteoclast fusion via Pmepa1
por: Molstad, David H. H., et al.
Publicado: (2020)

RB1 loss overrides PARP inhibitor sensitivity driven by RNASEH2B loss in prostate cancer
por: Miao, Chenkui, et al.
Publicado: (2022)

Replicative stress in gastroesophageal adenocarcinoma is associated with chromosomal instability and sensitivity to DNA damage response inhibitors
por: Sahgal, Pranshu, et al.
Publicado: (2023)

Preliminary Results about Lamb Meat Tenderness Based on the Study of Novel Isoforms and Alternative Splicing Regulation Pathways Using Iso-seq, RNA-seq and CTCF ChIP-seq Data
por: Yuan, Zehu, et al.
Publicado: (2022)

EASI—enrichment of alternatively spliced isoforms
por: Venables, Julian P., et al.
Publicado: (2006)

A Network of Splice Isoforms for the Mouse
por: Li, Hong-Dong, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_2olbmse7bl2122p2jrnhc9h173